Q3 2025 Holdings
Filed 2025-11-14 | 27 holdings | $659.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $112.5M | 1,325,000 | 17.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $95.1M | 2,416,667 | 14.4% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $44.8M | 17,050,000 | 6.8% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $41.3M | 2,874,111 | 6.3% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $36.4M | 1,971,054 | 5.5% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $30.7M | 2,624,000 | 4.6% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $29.7M | 9,067,500 | 4.5% |
| Merus N V | COM | N5749R100 | $29.0M | 308,000 | 4.4% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $25.8M | 2,815,000 | 3.9% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $25.1M | 2,130,000 | 3.8% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $20.4M | 903,500 | 3.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $20.4M | 360,000 | 3.1% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $20.1M | 830,000 | 3.1% |
| Cidara Therapeutics Inc(CDTX)Call | COM NEW | 171757206 | $19.2M | 200,000 | 2.9% |
| Pharvaris N V(PHVS) | COM | N69605108 | $18.0M | 722,595 | 2.7% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $15.5M | 1,273,333 | 2.4% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $14.1M | 1,115,000 | 2.1% |
| Bridgebio Oncology Therapeut(BBOT) | COM NEW | 107924102 | $12.1M | 1,043,110 | 1.8% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $10.2M | 1,018,021 | 1.5% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $9.7M | 2,633,334 | 1.5% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $9.6M | 100,000 | 1.5% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $4.6M | 177,667 | 0.7% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $4.4M | 252,000 | 0.7% |
| Unicycive Therapeutics Inc(UNCY) | COM NEW | 90466Y202 | $4.4M | 1,000,000 | 0.7% |
| Pepgen Inc(PEPG) | COM | 713317105 | $3.2M | 700,000 | 0.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $3.2M | 115,000 | 0.5% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 02/10/202 | 67080N119 | $385.2K | 104,112 | 0.1% |